Why depression and anxiety often travel together: the role of ketamine for comorbid depression anxiety
Depression and anxiety frequently co-occur because they share overlapping symptoms and clinical patterns. The comorbidity of anxiety and depression affects approximately 60% of people with either condition, creating a feedback loop where each disorder amplifies the other. Anxiety fuels hypervigilance and rumination, which deplete emotional energy. That exhaustion then deepens depressive symptoms, making it harder to engage in activities that might provide relief. Meanwhile, depression erodes the cognitive flexibility needed to manage anxious thoughts.
Traditional antidepressants like SSRIs (selective serotonin reuptake inhibitors) typically target serotonin alone, which means they may only partially address one condition while leaving the other unresolved. Research confirms that comorbid populations face treatment resistance with classical antidepressants. In clinical practice, depression that is not complicated by comorbidity is the exception, not the rule. Many people cycle through multiple medications, experiencing side effects like weight gain or emotional blunting without achieving durable relief.
Understanding this overlap is the first step toward recognizing why a treatment that addresses the shared biology driving both conditions, like IV (intravenous) ketamine, medication delivered directly into the bloodstream via a vein, can offer a different pathway forward for dual-diagnosis depression and anxiety.
How a ketamine infusion for depression and anxiety works
Ketamine infusion for depression and anxiety works by temporarily blocking NMDA receptors in the brain, triggering a rapid surge of glutamate that activates pathways essential for synaptic repair and emotional regulation. NMDA receptors (N-methyl-D-aspartate receptors) normally regulate glutamate activity, the brain’s primary excitatory neurotransmitter. When ketamine blocks these receptors, it stimulates the release of Brain-Derived Neurotrophic Factor (BDNF) and activates the mTORC1 pathway, which supports the growth of new synapses and repairs neural circuits damaged by chronic stress. In simpler terms, ketamine helps the brain rebuild connections that depression and anxiety have weakened over time, a process called neuroplasticity (the brain’s ability to reorganize itself by forming new neural connections).
Both depression and anxiety involve dysfunction in the brain’s stress-response system (the HPA axis, or hypothalamic-pituitary-adrenal axis) and disruptions in glutamate signaling. Chronic stress leads to sustained cortisol production, which causes neuroinflammation and structural changes in brain regions responsible for mood regulation, particularly the prefrontal cortex and hippocampus. Because these pathways are intertwined, IV ketamine depression anxiety treatment offers a unique advantage: it targets the shared biology driving both conditions simultaneously, rather than treating them as separate problems.
A 2016 study on ketamine’s mechanism explains that the rapid-acting antidepressant effects result from this specific cascade: blockade of interneuronal NMDA receptors leads to a glutamate surge, activation of AMPA receptors, and ultimately the stimulation of synaptogenic pathways that restore healthy brain function. Unlike traditional antidepressants that can take weeks or months to show benefit, ketamine’s effects on mood can begin within hours.
Research on ketamine’s effects in dual-diagnosis populations found concordant reduction in both depression and anxiety symptoms with repeat infusions, meaning that improvements in one condition were matched by improvements in the other. Comorbid anxiety symptoms did not diminish the antidepressant effects of ketamine, which stands in contrast to traditional medications that may prioritize one symptom cluster over another.
The neuroplastic window that ketamine opens is especially powerful when paired with intentional integration, the process of translating insights and emotional shifts from your session into tangible changes in daily life. Studies show that ketamine boosts BDNF production and stimulates the formation of new synapses, creating a period of enhanced neuroplasticity. This is why the days following a session are so critical: your brain is in a heightened state of receptivity, primed to form new neural connections and rewrite old patterns. To learn more, explore the neuroscience of ketamine .
The patient experience: a step-by-step guide to the infusion session
A ketamine infusion session consists of approximately 60 minutes from start to finish, including preparation, the 40-minute infusion, and a period of guided integration. The entire experience unfolds as a carefully structured therapeutic arc designed to ensure both medical safety and emotional depth.
Preparation (minutes 0–15):
Your session begins with a thorough medical check-in conducted by your care team who will assess your vital signs and answer any questions. You’ll settle into a comfortable treatment chair designed to allow your body to fully relax. You’ll be offered an eye mask and noise-canceling headphones with a curated music playlist. A brief guided meditation helps you set an intention for the session, grounding you in what you hope to explore or release.
Onset (minutes 15–20):
The IV infusion begins at an individualized dose, typically ranging from 0.5 to 1.0 mg per kilogram of body weight, based on your medical history and comfort level. This sub-anesthetic dose is carefully calibrated to produce therapeutic effects while maintaining safety and comfort. You may notice a gentle heaviness or warmth spreading through your body. Some members describe this as a feeling of deep relaxation, as though they’re sinking into the chair. The onset is gradual, allowing you to ease into the experience.
Peak experience (minutes 20–50):
During the peak, you may enter a dissociative state, a temporary shift in consciousness where you feel like an observer of your own thoughts. This detachment can be profoundly helpful for people living with anxiety, as it creates space between you and the cycle of worry. You might experience visual patterns or a sense of floating. Throughout this phase, your care team monitors your vitals continuously to ensure your safety and comfort.
Return and integration (minutes 50–60):
As the infusion ends, you’ll gradually return to your baseline state of awareness. Many members find it helpful to remain seated for a few minutes. This is often when initial insights surface: fleeting impressions, emotional releases, or moments of clarity. Your care team will provide guidance for the integration work that begins in the hours that follow. To prepare, review preparing for ketamine treatment .
Why IV delivery offers distinct advantages for ketamine treatment
IV ketamine is the gold standard because it ensures 100% bioavailability and allows for precise, real-time dose titration by your physician, providing unmatched predictability and control. This predictability is critical, especially for members who fear losing control or feeling overwhelmed during the session.
One of the most reassuring aspects of IV ketamine is that the infusion can be slowed or stopped immediately if discomfort arises. Unlike oral ketamine, which must pass through the digestive system and is subject to unpredictable first-pass metabolism, IV administration allows your physician to adjust the dose in real time based on your response. This level of control provides a degree of precision and safety monitoring that differs from at-home or intranasal methods, where absorption rates may vary and real-time clinical oversight is limited.
Continuous monitoring by trained medical staff ensures that your vital signs remain stable throughout the session. The strict dosing protocols at Nushama, including secure storage, physician-only dosing, and RN administration, reflect a commitment to safety that goes beyond what telehealth or unsupervised models can offer.
Clinical evidence suggests that IV ketamine often demonstrates faster onset of therapeutic effects compared to intranasal esketamine (Spravato), with IV administration offering 75% response rates in treatment-resistant depression compared to 30-40% for intranasal delivery, largely due to the superior bioavailability of IV administration. For members seeking the most effective pathway to relief, IV infusion remains the gold standard.
Integration: turning the experience into durable change
Integration turns the ketamine experience into durable change by utilizing the period of enhanced neuroplasticity to establish new cognitive patterns through journaling, therapy, and reflection. The infusion itself is a catalyst, but the real transformation happens in the days that follow. Research indicates that ketamine’s neuroplastic effects create a window of opportunity when your brain is uniquely receptive to forming new connections. During this time, integration practices like meditation and emotional processing can have more lasting effects.
Integration is the process of translating the insights and emotional shifts from your session into tangible changes in your daily life. This might mean working with a therapist to process difficult memories, exploring new coping strategies for anxiety, or simply giving yourself permission to rest and reflect. At Nushama, integration coaching and group circles provide structured support, helping you make sense of the experience and connect with others on a similar journey.
It’s important to know that healing is not linear. Some members experience a dip in mood or energy in the days following a session before they feel a sustained lift. This is a normal part of the process, and it’s why ongoing support is so valuable. The neuroplasticity that ketamine initiates is temporary, but the habits and insights you build during the integration window can last. To dive deeper into why this phase is essential, read more about the importance of ketamine integration .
Frequently asked questions
The following questions address common concerns about safety, timeline, and the practical aspects of ketamine therapy for dual-diagnosis depression and anxiety.
Q: Will I lose control during the session?
A: You will not lose control in the way you might fear. The dissociative state that ketamine produces typically lasts during the 40-minute infusion period and is continuously monitored by trained medical staff. You remain awake and able to communicate with your care team throughout. The eye mask and curated music create a secure container, helping you feel held rather than overwhelmed. Many members describe the sensation as observing their thoughts from a distance, which can reduce anxiety by breaking the cycle of rumination.
Q: How quickly will I see results for both anxiety and depression?
A: Relief can often begin within hours of your first infusion, though the timeline varies. Research on ketamine for dual-diagnosis conditions shows concordant symptom reduction across both depression and anxiety, meaning improvements in one often accompany improvements in the other. NIMH data confirms that ketamine works within hours to strongly reduce depressive symptoms, especially in people for whom other treatments have not worked.
Q: Is ketamine safe if I have high anxiety?
A: Yes, ketamine is safe for people with high anxiety when administered in a medically supervised setting. According to NIMH studies, side effects such as feeling “strange or loopy” peak within one hour and typically resolve within two hours. The calming environment at Nushama, combined with dose titration and continuous monitoring, minimizes anxiety triggers. The infusion can be slowed or stopped immediately if you feel uncomfortable.
Q: How many sessions are recommended?
A: The standard induction protocol involves six infusions administered over three weeks, typically scheduled twice per week. Dosing is individualized based on your body weight, treatment response, and overall comfort level, with therapeutic doses generally ranging from 0.5 to 1.0 mg per kilogram. After the initial series, your care team will work with you to determine if maintenance sessions are helpful. You can learn more about ketamine dosing explained .
Q: Can I stay on my current medications?
A: In most cases, yes, but this is a conversation to have directly with Nushama’s care team during your consultation. Many members continue their current medication regimen during ketamine therapy, as there are no absolute contraindications with most psychiatric medications. However, certain drugs or health conditions may require dose adjustments or additional monitoring. A thorough medical screening ensures that your treatment plan is both safe and effective.
If you’re ready to explore how ketamine can support your mental health journey, book a consultation with our care team.
